| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 415.3K | $30.85M | -7,500 | |
| VP | 141.5K | $10.51M | - | |
| Other | 87.3K | $6.49M | - | |
| Dir | 75.2K | $5.59M | - | |
| CFO | 70.1K | $5.21M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Malik Fady Ibraham56 | EVP Research &Development | Sale+OE | 2,200 | $63.89 | $140,558.00 | -1.5% | -3.2% | - | |
| Dec 2, 2025 | Henderson John T65 | Director | Sale+OE | 8,750 | $63.90 | $559,125.00 | -10.5% | -3.2% | - | |
| Dec 1, 2025 | Kaye Edward M. Md47 | Director | Sale+OE | 28,064 | $66.72 | $1,872,430.08 | -73.8% | -6.9% | - | |
| Dec 1, 2025 | Harrington Robert Arthur51 | Director | Sell | 2,150 | $66.80 | $143,620.00 | -10.4% | -6.9% | - | |
| Nov 19, 2025 | Parshall B Lynne74 | Director | Sell | 5,000 | $64.73 | $323,650.00 | -17.9% | +2.8% | - | |
| Nov 18, 2025 | Malik Fady Ibraham56 | EVP Research &Development | Sale+OE | 2,200 | $66.45 | $146,190.00 | -1.5% | +0.7% | - | |
| Nov 11, 2025 | Kaye Edward M. Md47 | Director | Sale+OE | 5,175 | $65.08 | $336,789.00 | -34.2% | -4.7% | - | |
| Nov 4, 2025 | Malik Fady Ibraham56 | EVP Research &Development | Sale+OE | 2,295 | $59.55 | $136,667.25 | -1.6% | +9.3% | - | |
| Oct 30, 2025 | Blum Robert I51 | President &CEO | Sell | 5,000 | $62.86 | $314,300.00 | -1.4% | +4.6% | - | |
| Oct 27, 2025 | Wierenga Wendell | Director | Sale+OE | 4,375 | $58.68 | $256,725.00 | -11.9% | +5.0% | - |